Michael Woudenberg
CIK: 0001817884
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
InMed Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 19, 2025INM
InMed Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
18K shares- - Dec 15, 2025INM
InMed Pharmaceuticals Inc.
Expiration (Short)(H)DirectEmployee Stock Option (Expiration)
60 shares- - Dec 20, 2024INM
InMed Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
3.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 19, 2025 | INM InMed Pharmaceuticals Inc. | Award(A) Employee Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| Dec 15, 2025 | INM InMed Pharmaceuticals Inc. | Expiration (Short)(H) Employee Stock Option (Expiration) | 60 | - | - | Direct |
| Dec 20, 2024 | INM InMed Pharmaceuticals Inc. | Award(A) Employee Stock Option (Right to Buy) | 3,750 | - | - | Direct |
1-3 of 3 transactions
About WOUDENBERG MICHAEL
WOUDENBERG MICHAEL (SEC CIK 0001817884) files insider reports with the SEC as Chief Operating Officer of InMed Pharmaceuticals Inc. (INM).
Signal8 holds 3 ownership filings by WOUDENBERG MICHAEL, all Form 4s, filed between Dec 23, 2024 and Dec 19, 2025. Those filings report 3 transactions, from Dec 20, 2024 to Dec 19, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on WOUDENBERG MICHAEL's filings is in VANCOUVER, A1.
Recent filings by WOUDENBERG MICHAEL
Other insiders filing for InMed Pharmaceuticals Inc. (INM)
- ADAR1 Capital Management, LLC, 10% Owner
- Vivo Opportunity, LLC, 10% Owner
- Johnson Shane Aaron, Sr VP & General Manager
- Lemerond Nicole, Director
- Klompas Neil A, Director
- Jagpal Netta, Chief Financial Officer